Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Run-in, Followed by a Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Show the Effectiveness of Buprenorphine Transdermal System in Management of Patients With Chronic Nonmalignant Pain Syndromes

NCT00312195 is registered in ClinicalTrials.gov with Purdue Pharma LP as lead sponsor.

NCT NCT00312195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00312195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Run-in, Followed by a Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Show the Effectiveness of Buprenorphine Transdermal System in Management of Patients With Chronic Nonmalignant Pain Syndromes
Lead sponsor
Purdue Pharma LP
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2001
Completion date
July 31, 2001
Enrollment
267 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

chronic non-malignant pain